Central nervous system aspergillosis in immunocompetent patients: Case series and literature review.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
30 10 2020
Historique:
entrez: 31 10 2020
pubmed: 1 11 2020
medline: 13 11 2020
Statut: ppublish

Résumé

The aim of this study was to investigate the clinical characteristics of central nervous system (CNS) aspergillosis in immunocompetent patients.This study enrolled six immunocompetent patients diagnosed with CNS aspergillosis. Additionally, we reviewed the clinical profiles for 28 cases reported in the literature. The age, gender, etiology of Aspergillus infection, clinical manifestations, location of the lesion, treatment, and prognosis were analyzed.There were 19 men (average age, 54.6 ± 14.3 years) and 15 women (average age, 47.0 ± 19.4 years). The clinical manifestations included headache (55.9%; n = 19), visual impairment (32.4%; n = 11), diplopia (32.4%; n = 11), hemiplegia (20.6%; n = 7), fever (17.6%; n = 6), and epilepsy (8.8%; n = 3). According to the radiological features, CNS aspergillosis lesions were divided into two subtypes: parenchymal lesions in the cerebral lobes (n = 11), and meningeal lesions in the meninges (n = 23). The patients with meningeal lesions are easy to be complicated with more serious cerebrovascular diseases, such as subarachnoid hemorrhage and massive infarction. Most of the lesions in brain parenchyma were abscess formation, and magnetic resonance imaging showed ring enhancement. The clinical diagnosis of Aspergillus infection was mainly based on brain biopsy (n = 14), autopsy (n = 8), pathological examination of adjacent brain tissues (n = 7), cerebrospinal fluid (CSF) or tissue culture (n = 3), and second-generation sequencing analysis of the CSF (n = 3). Clinical improvement was achieved in 23 cases, and 11 patients succumbed to the disease. Voriconazole treatment was effective in 24 (70.6%) cases.Immunocompetent subjects are also at risk for Aspergillus infections. Concomitant cerebrovascular diseases are common in patients with CNS aspergillosis, especially in patients with meningeal aspergillosis. Parenchymal aspergillosis lesions are usually localized and manifest as brain abscesses with annular enhancement on magnetic resonance imaging. Biopsy, CSF culture, and next-generation sequencing are mainstream diagnostic modalities. Voriconazole is an effective treatment for Aspergillus infection, and early diagnosis and treatment should be highlighted.

Identifiants

pubmed: 33126348
doi: 10.1097/MD.0000000000022911
pii: 00005792-202010300-00052
pmc: PMC7598844
doi:

Substances chimiques

Antifungal Agents 0
Voriconazole JFU09I87TR

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22911

Références

J Neuroimaging. 2007 Oct;17(4):361-6
pubmed: 17894631
Postgrad Med J. 2019 Jul;95(1125):382-389
pubmed: 31221685
Auris Nasus Larynx. 2015 Dec;42(6):501-4
pubmed: 26025177
Diseases. 2018 May 31;6(2):
pubmed: 29857501
Clin Infect Dis. 2008 Feb 1;46(3):327-60
pubmed: 18177225
Hum Pathol. 2002 Jan;33(1):116-24
pubmed: 11823982
BMC Res Notes. 2014 Oct 04;7:689
pubmed: 25280605
Int J Neurosci. 2017 Apr;127(4):339-343
pubmed: 26978276
PLoS One. 2016 Apr 20;11(4):e0152475
pubmed: 27097323
J Neuroophthalmol. 2016 Dec;36(4):404-407
pubmed: 27031126
Ann Neurol. 1985 Nov;18(5):574-82
pubmed: 3935042
Auris Nasus Larynx. 2015 Dec;42(6):488-91
pubmed: 26003880
AJNR Am J Neuroradiol. 1999 Oct;20(9):1597-604
pubmed: 10543627
No To Shinkei. 1988 Mar;40(3):225-32
pubmed: 3395519
Int J Clin Exp Pathol. 2015 Oct 01;8(10):13510-22
pubmed: 26722566
N Engl J Med. 2012 Nov 29;367(22):2119-25
pubmed: 23083311
J Pak Med Assoc. 2010 Jul;60(7):573-9
pubmed: 20578611
Front Med (Lausanne). 2017 Jul 18;4:113
pubmed: 28770205
Int J Antimicrob Agents. 2014 Feb;43(2):165-9
pubmed: 24315314
Mycopathologia. 2017 Jun;182(5-6):527-538
pubmed: 28054219
Int J Clin Exp Med. 2015 Nov 15;8(11):20524-31
pubmed: 26884969
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):179-182
pubmed: 29528023
J Neuroradiol. 2018 May;45(3):169-176
pubmed: 29273531
Mycoses. 2006 Jan;49(1):30-6
pubmed: 16367816
World Neurosurg. 2014 Jul-Aug;82(1-2):e325-33
pubmed: 24076053
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Feb;119(2):e60-4
pubmed: 25487984
Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413-37
pubmed: 2502407
J Emerg Med. 2010 Jun;38(5):597-600
pubmed: 18687566

Auteurs

Yubao Ma (Y)

Department of Neurology, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Haidian District, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH